NLS Pharmaceutics Ltd. ("NLS"), a Swiss clinical-stage biopharmaceutical company focused on central nervous system and neurodegenerative disorders and Kadimastem Ltd. ("Kadimastem"), a clinical-stage ...
DNA, often called the blueprint of life, is built from four chemical building blocks known as deoxy-nucleoside triphosphates ...
An international research team led by Hiroki Shibuya at RIKEN Center for Biosystems Dynamics Research (BDR) in Japan has ...
1don MSN
Clinical trial presents promising DNA-encoded therapy for long-lasting protection against COVID-19
A new way to deliver protective antibodies against COVID-19 was tested in a Phase I clinical trial. Instead of injecting ...
According to Precedence Research, the global animal healthcare market size will grow from USD 73.10 billion in 2025 to nearly ...
To solve this critical challenge, he founded Nephrogen in 2022, a biotech startup that uses AI and advanced screening to ...
As part of the 8th International Symposium on Membrane Technologies and Applications (MEMTEK 2025), to be held on November 12 ...
Artificial untelligence (AI) stocks under $10 are publicly traded companies developing or applying AI technologies, with stock prices below $10 per share. These lower-priced AI stocks can present ...
Computational Nanoscience in the Quantum and AI Era: Integrating Biomolecular and Materials Modeling
The past decade has witnessed remarkable advances in computational power, algorithms, and theoretical methods, enabling accurate modeling and prediction of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback